Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Specific PXR antagonist 70

Copy Product Info
😃Good
Catalog No. T41255Cas No. 931314-31-7

Specific PXR antagonist 70 is a selective pregnane X receptor (PXR) antagonist with an IC50 of 540 nM and Ki of 390 nM for human PCR and enhances the chemosensitivity of cancer cells.

Specific PXR antagonist 70

Specific PXR antagonist 70

Copy Product Info
😃Good
Purity: 98.41%
Catalog No. T41255Cas No. 931314-31-7
Specific PXR antagonist 70 is a selective pregnane X receptor (PXR) antagonist with an IC50 of 540 nM and Ki of 390 nM for human PCR and enhances the chemosensitivity of cancer cells.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$48In StockIn Stock
5 mg$106In StockIn Stock
10 mg$147In StockIn Stock
25 mg$239In StockIn Stock
50 mg$372In StockIn Stock
100 mg$538In StockIn Stock
500 mg$1,150-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
This molecule is a custom-made product. TargetMol has an excellent synthesis team with the experience and capability to provide you with cost-effective products.If you have any questions, please feel free to contact us. We are committed to serving you wholeheartedly.
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:98.41%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Specific PXR antagonist 70 AI Summary
Specific PXR antagonist 70 demonstrates various bioactivities related to human Pregnane X Receptor (PXR) and CRBN/DDB1 complex interactions. For PXR, it shows significant displacement of BODIPY FL vindoline from GST-tagged PXR LBD, with an IC50 of 190.0 nM and 95.0% inhibition at 10 µM. It also acts as an inverse agonist in HepG2 cells with an IC50 of 24.0 nM, and inhibits PXR activity in the presence of rifampicin, with an IC50 of 250.0 nM and 100% inhibition at 10 µM. In contrast, for the CRBN/DDB1 complex, it displays relatively low potency with an EC50 greater than 3000.0 nM in displacement of BODIPY FL thalidomide. Overall, Specific PXR antagonist 70 shows strong modulation potential for PXR-regulated pathways but relatively low activity in the context of CRBN/DDB1 complex interaction..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
Specific PXR antagonist 70 is a selective pregnane X receptor (PXR) antagonist with an IC50 of 540 nM and Ki of 390 nM for human PCR and enhances the chemosensitivity of cancer cells.
Chemical Properties
Molecular Weight415.51
FormulaC21H25N3O4S
Cas No.931314-31-7
SmilesCOC1=CC=C(OC)C(=C1)N1N=NC(=C1C)S(=O)(=O)C1=CC=C(C=C1)C(C)(C)C
Relative Density.1.22 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
H2O: 76.92 mg/mL (185.12 mM), Sonication is recommended.
Solution Preparation Table
H2O
1mg5mg10mg50mg
1 mM2.4067 mL12.0334 mL24.0668 mL120.3340 mL
5 mM0.4813 mL2.4067 mL4.8134 mL24.0668 mL
10 mM0.2407 mL1.2033 mL2.4067 mL12.0334 mL
20 mM0.1203 mL0.6017 mL1.2033 mL6.0167 mL
50 mM0.0481 mL0.2407 mL0.4813 mL2.4067 mL
100 mM0.0241 mL0.1203 mL0.2407 mL1.2033 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Specific PXR antagonist 70 | purchase Specific PXR antagonist 70 | Specific PXR antagonist 70 cost | order Specific PXR antagonist 70 | Specific PXR antagonist 70 chemical structure | Specific PXR antagonist 70 formula | Specific PXR antagonist 70 molecular weight